Literature DB >> 30291807

Will my child do better if she enrolls in a clinical trial?

Malcolm A Smith1, Steven Joffe2,3.   

Abstract

The question of whether children with cancer who enroll in clinical trials have superior outcomes compared with those who do not participate has been pursued for more than 4 decades, and recent studies have provided conflicting answers. Whether clinical trial participation influences outcome has important implications for how clinicians should present trial participation to patients and families. Methodological challenges limit generalizations about the impact of clinical trial participation on outcome compared with nonparticipation. Oncologists should inform patients and families that clinical trials are the engine for future progress because they identify more effective therapies and that clinical trial participation is a reasonable option to consider for children with cancer. However, as noted in by Truong and colleagues in this issue, the rationale for trial enrollment should not include an expectation of better outcomes compared with nonenrollment.
© 2018 American Cancer Society.

Entities:  

Keywords:  childhood cancer; clinical trials; informed consent; research ethics; selection bias

Mesh:

Year:  2018        PMID: 30291807     DOI: 10.1002/cncr.31722

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Evaluation of the Pediatric Research Participation Questionnaire for Measuring Attitudes Toward Cancer Clinical Trials Among Adolescents and Young Adults.

Authors:  Lamia P Barakat; Evelyn Stevens; Yimei Li; Anne Reilly; Janet A Deatrick; Naomi E Goldstein; Lisa A Schwartz
Journal:  J Adolesc Young Adult Oncol       Date:  2019-04-26       Impact factor: 2.223

Review 2.  A roadmap to using historical controls in clinical trials - by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG).

Authors:  Mercedeh Ghadessi; Rui Tang; Joey Zhou; Rong Liu; Chenkun Wang; Kiichiro Toyoizumi; Chaoqun Mei; Lixia Zhang; C Q Deng; Robert A Beckman
Journal:  Orphanet J Rare Dis       Date:  2020-03-12       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.